Kettritz Ralph
Dtsch Med Wochenschr. 2024 Feb;149(3):86-92. doi: 10.1055/a-2055-3486. Epub 2024 Jan 23.
Osmotic gradients over cell membranes lead to water movement into or out of cells. An intact osmoregulation prevents osmotic gradients, thereby protecting cells from swelling or shrinking. Na is the major cation in the extracellular fluid (ECF) and the major determinant of the osmolarity in the ECF, including plasma. Therefore, the plasma-Na concentration needs to be tightly regulated. An excess of electrolyte-free water decreases the concentration of osmolytes leading to hyponatremia. In contrast, a free water deficit increases the osmolyte concentration leading to hypernatremia. Pathophysiology-oriented approaches to dysnatremic patients help both clinicians and patients. Therapeutic interventions depend on the differentiation between acute and chronic, asymptomatic, and symptomatic dysnatremia, and on the patient's extracellular volume status. The therapeutic armamentarium for hyponatremia consists of water restriction, hypertonic infusions, urea, V2 receptor-blockers, and sodium-glucose cotransporter 2 (SGLT2) inhibitors. Patients with hypernatremia are treated with electrolyte-free water or hypotonic sodium-containing solutions depending on their volume status. Basic concepts in the management of dysnatremic patients are discussed.
细胞膜上的渗透梯度导致水进出细胞。完整的渗透压调节可防止渗透梯度,从而保护细胞免于肿胀或萎缩。钠是细胞外液(ECF)中的主要阳离子,也是包括血浆在内的ECF渗透压的主要决定因素。因此,血浆钠浓度需要严格调节。无电解质水过多会降低渗透溶质浓度,导致低钠血症。相反,自由水缺乏会增加渗透溶质浓度,导致高钠血症。针对低钠血症患者的病理生理学方法对临床医生和患者都有帮助。治疗干预取决于急性和慢性、无症状和有症状低钠血症之间的区分,以及患者的细胞外液量状态。低钠血症的治疗手段包括限水、高渗输注、尿素、V2受体阻滞剂和钠-葡萄糖协同转运蛋白2(SGLT2)抑制剂。高钠血症患者根据其容量状态用无电解质水或低渗含钠溶液治疗。本文讨论了低钠血症患者管理的基本概念。